Prelude Therapeutics Incorporated — Quarterly Financial Statistics (NASDAQ:PRLD) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -20.74 M-34.23 M-26.07 M-19.11 M23.12 M -56.3 M Cash from investing activities 22.12 M62.19 M11.52 M40.09 M-60.34 M 53.46 M Cash from financing activities -34 K-160 K37 K-5 00024.94 M 24.82 M Free cash flow -20.8 M-34.28 M-26.09 M-19.11 M23.12 M -56.37 M

뉴스

프렐루드 테라퓨틱스, Jefferies 통해 최대 2,500만 달러 규모 주식 공모

Prelude Therapeutics files to offer up to $25 million in stock through Jefferies

프렐루드 테라퓨틱스, JAK2 잠재력에 시티즌스 목표가 상향

Citizens raises Prelude Therapeutics price target on JAK2 potential

프렐류드 테라퓨틱스, Citizens에서 ’시장 수익률 상회’ 등급 재확인

Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens

프렐루드 테라퓨틱스, FDA의 암 치료제 IND 승인 후 주가 급등

Prelude Therapeutics stock surges after FDA clears IND for cancer drug

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens

Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus

프렐루드 테라퓨틱스, Citizens, ’시장수익률 상회’ 등급 재확인